Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genetic testing and public policy.

Literature DB >> 9549463

Genetic testing and public policy.

Abstract

Keywords: Advisory Committee on Genetic Testing (Great Britain); British Insurers Code of Practice; Genetics and Reproduction; Health Insurance Portability and Accountability Act 1996; Human Genetics Advisory Commission (Great Britain); National Health Service; Task Force on Genetic Testing

Mesh：

Year: 1998 PMID： 9549463 PMCID： PMC1112777 DOI： 10.1136/bmj.316.7134.852

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

25 in total

1. Self-critical federal science? The ethics experiment within the U.S. Human Genome Project.

Authors: Eric T Juengst
Journal: Soc Philos Policy Date: 1996

2. Individual, family, and societal dimensions of genetic discrimination: a case study analysis.

Authors: Lisa N Geller; Joseph S Alper; Paul R Billings; Carol I Barash; Jonathan Beckwith; Marvin R Natowicz
Journal: Sci Eng Ethics Date: 1996-01 Impact factor: 3.525

3. Discrimination as a consequence of genetic testing.

Authors: P R Billings; M A Kohn; M de Cuevas; J Beckwith; J S Alper; M R Natowicz
Journal: Am J Hum Genet Date: 1992-03 Impact factor: 11.025

4. "Code of practice and guidance on human genetic testing services supplied direct to the public". Advisory Committee on Genetic Testing.

Authors: J C Barber
Journal: J Med Genet Date: 1998-06 Impact factor: 6.318

5. Genetic discrimination and health insurance: an urgent need for reform.

Authors: K L Hudson; K H Rothenberg; L B Andrews; M J Kahn; F S Collins
Journal: Science Date: 1995-10-20 Impact factor: 47.728

6. MPs challenge rejection of genetics panel.

Authors: D Dickson
Journal: Nature Date: 1996-01-18 Impact factor: 49.962

Review 7. Screening for colorectal cancer.

Authors: N W Toribara; M H Sleisenger
Journal: N Engl J Med Date: 1995-03-30 Impact factor: 91.245

8. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.

Authors: C Lerman; S Narod; K Schulman; C Hughes; A Gomez-Caminero; G Bonney; K Gold; B Trock; D Main; J Lynch; C Fulmore; C Snyder; S J Lemon; T Conway; P Tonin; G Lenoir; H Lynch
Journal: JAMA Date: 1996-06-26 Impact factor: 56.272

Review 9. Response to treatment in hereditary metabolic disease: 1993 survey and 10-year comparison.

Authors: E Treacy; B Childs; C R Scriver
Journal: Am J Hum Genet Date: 1995-02 Impact factor: 11.025

10. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.

Authors: S Seshadri; D A Drachman; C F Lippa
Journal: Arch Neurol Date: 1995-11

9 in total

Genetic testing and public policy.

1. Self-critical federal science? The ethics experiment within the U.S. Human Genome Project.

2. Individual, family, and societal dimensions of genetic discrimination: a case study analysis.

3. Discrimination as a consequence of genetic testing.

4. "Code of practice and guidance on human genetic testing services supplied direct to the public". Advisory Committee on Genetic Testing.

5. Genetic discrimination and health insurance: an urgent need for reform.

6. MPs challenge rejection of genetics panel.

Review 7. Screening for colorectal cancer.

8. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.

Review 9. Response to treatment in hereditary metabolic disease: 1993 survey and 10-year comparison.

10. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.

1. Challenges to the economic evaluation of new biotechnological interventions in healthcare.

2. Genetic discrimination and mental illness: a case report.

3. Appraising organised screening programmes for testing for genetic susceptibility to cancer.

4. The genetics of tobacco use: methods, findings and policy implications.

5. A research agenda for assessing the potential contribution of genomic medicine to tobacco control.

Review 6. Democratising access to genetic services.

7. Where are we going with preimplantation genetic diagnosis?

8. Will nicotine genetics and a nicotine vaccine prevent cigarette smoking and smoking-related diseases?

9. The Return of Lombroso? Ethical Aspects of (Visions of) Preventive Forensic Screening.